Skip to content
Surf Wiki
Save to docs
general/2-aminotetralins

From Surf Wiki (app.surf) — the open knowledge base

MDAT

Chemical compound


Chemical compound

FieldValue
image6,7-Methylenedioxy-2-aminotetralin.svg
image_classskin-invert-image
width250px
classSerotonin releasing agent; Entactogen
ATC_prefixNone
legal_statusUncontrolled
index2_labelhydrochloride
CAS_number_Ref
CAS_number101625-35-8
CAS_number2_Ref
CAS_number23446-21-8
UNII_Ref
UNII28IR5LC41Q
UNII2_Ref
UNII2BOX4U52EET
PubChem36483
ChemSpiderID33531
synonyms6,7-MDAT; 6,7-Methylenedioxy-2-aminotetralin
IUPAC_name5,6,7,8-tetrahydrobenzo[f][1,3]benzodioxol-6-amine
C11H=13N=1O=2
SMILESC3Cc1cc2OCOc2cc1CC3N

MDAT, also known as 6,7-methylenedioxy-2-aminotetralin, is a drug of the 2-aminotetralin family developed in the 1990s by a team at Purdue University led by David E. Nichols. It appears to act as a serotonin releasing agent based on rodent drug discrimination assays comparing it to MDMA, in which it fully substitutes for, and additionally lacks any kind of serotonergic neurotoxicity. Hence, MDAT is considered likely to be a non-neurotoxic, putative entactogen in humans.

References

References

  1. (February 1990). "Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about MDAT — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report